
Pharma Marketing Blog represents the opinions of John Mack Publisher of Pharma Marketing News.
We accept advertising relevant to the interests of our members. For more information, see:
Media Kit
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
|

Advertising Information |
FAQs |
About Us |
Contact Us |
Privacy Policy
Legal & Regulatory Blog Posts
| Return to All Pharma Marketing Blog Topics |
The following Pharma Marketing Blog posts focus on guidelines, regulations, and laws applicable to pharmaceutical marketing and sales.
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
Click on title to access full-text post in new browser window.
Posted in 2009:
- Transcripts of FDA's November 2009 Public Hearing ...
- Atlas Did NOT Shrug! FDA Makes (Some) Comments Pub...
- Dear FDA: Where Are the Public Comments Regarding ...
- FDA Intern & the Next Steps Toward Pharma Social M...
- Is Google the New FDA?
- FDA Social Media Guidelines Best Done in Baby Step...
- FDA Social Media Hearing Day 1: My Key Takeaways
- I'm Off to FDA Hearing: Here's What I Plan to Show...
- FDA Panelists at the Upcoming Social Media Public ...
- PhRMA Proposes FDA-Approved Use of Universal Safe...
- FDA Public Hearing: Not Deja Vu All Over Again?
- My FDA Social Media Hearing Presentations
- Industry Groups will Eat Consumer Advocates' Lunch...
- Social Media Best Practices for Pharma Are Needed,...
- Expect FDA Social Media Draft Guidance Before End ...
- Fear and Loathing in Washington, DC
- Pharma Social Media Crips vs. Legal/Regulatory Blo...
- I Will Present Survey Results at November FDA Hear...
- Boehringer's Branded Tweet Violates FDA Regulation...
- CEI's Critique of FDA's Paid Search Stance Should ...
- Are There Special Cases for Correcting Misinformat...
- How Should Pharma Companies Submit Social Media Co...
- Should Pharma Companies Correct Drug Misinformatio...
- Is FDA's Sponsored Search Advertising Policy Incre...
- Regulatory Solutions to Overcoming Space Limitatio...
- Pharma Prefers "1-Click Rule" for Presenting Fair ...
- 3rd Party Dissemination of Altered Rx Drug Informa...
- Should FDA Regulation Depend on Specific Media or ...
- When Are Third-Party Online Discussions Not Indepe...
- What Criteria Determine Substantive Pharma Influen...
- FDA Letters Caused a Prompt, Precipitous, & Prolon...
- What Techniques are Used by Pharma to Monitor Adve...
- Who Should Be Responsible for Submitting Adverse E...
- How is Adverse Event Information from Social Media...
- Challenges Handling Adverse Events Found on SM Sit...
- Uncertainties Regarding Reporting Adverse Events F...
- Get Your FDA Social Media Public Hearing T-Shirt!
- Pharma Influence Over 3rd-Party Conversations in S...
- Let's Respond to FDA's Questions Regarding Its Reg...
- FDA Announces Public Hearing on Promotion of Drugs...
- An Example of Non-Transparency Over at FDA's Trans...
- FDA Reads My Blog: Declares Latisse Web Site Misle...
- FDA Approves Depressant Drug For The Annoyingly Ch...
- Are Organic Search Results Next on FDA's Chopping ...
- Full BOEHR(inger) Social Media Reporting of RELY T...
- Will Alli Soon Be the Only FDA-UNapproved OTC Drug...
- No FDA Regulations Would Be Like Driving on a High...
- Senator Grassley Sees Pharma Ghost Writing Problem...
- FDA Cannot Track Its Own Review of Adverse Event R...
- Unintended Consequences of FDA Warnings: Lilly-funded Antidepressant Case Study
- Pristiq DTC Campaign Challenged to Concisely Communicate Risk
- Missing FDA Letters Found. More Questions.
- Regulatory Ranters Miss the Point About FDA's Position on Search Engine Ads
- Nasonex Bee May Usher In a Whole New Way to do FDA-friendly Pharma Tweets
- Acromegaly Answers Blog Raises Interesting Regulatory Question
- End All Pharma Freebies to Physicians by Decree or Just Leave it at Caveat Doctor?
- Distribution of Reprints: Another Example of FDA Flexing Its Enforcement Muscles
- Towards a Rational FDA Policy Addressing the Internet and Social Media
- FDA Rules are NOT Media Agnostic
- Arnold Friede Blasts FDA's Right to Define "Reasonable Man" Without External Input
- Uh, Oh! Will FDA Cite this "One-Click Rule" Twitter Post by AZ as Violative?
- Communicating Risk in Online Drug Ads: Reading the Tea Leaves in Recent FDA Draft Guidance
- Dear GSK: Precedent Should Not Guide Pharma's New Media Communications Strategy
- If Off-label Use of Anti Swine Flu Drugs are OK, Why Aren't Reminder Ads that Lack Fair Balance Also OK?
- What Good Can Come from a Public FDA Hearing on Social Media?
- Want to See Adverse Events of Drugs You are Taking? Try This Site
- FDA, Tear Down This Wall! A Draft Petition Calling for a Public Hearing
- New FDA Data: Adverse Event Reporting Increases Dramatically
- Twitter Lobbying Effort Calls Upon FDA to Convene a Public Hearing
- St. Google Slays the FDA Dragon?
- The Next FDA Concern May be the Use of "Redirect" URLs
- PhRMA Says FDA Should Initiate a Public Process Rather than Regulate by Warning Letter When it Comes to the Internet
- The 14 Letters. Who at the FDA Knew What and When? FDA Intern Wants to Know!
- FDA's Actions Speak Louder than Its Words: On the Internet It's the Medium as Well as the Message!
- FDA and Pharma - Bring More Stakeholders into Your Discussion of Social Media Guidelines! No More Joking!
- FDA Issues First-ever Draft Guidance on Pharma’s Use of Social Media!
- Faux Social Marketing: Have Your Cake and Eat It Too!
- Did I Miss the Fair Balance in Last Night's Omnaris Nasal Spray TV Commercial?
- Wolfe Defanged at FDA Advisory Committee Meeting on J&J's rivaroxaban
- FDA Lacks Credibility, Says Judge in Ruling to Allow Access to Plan B by 17-year-old Women
- Pharma Dreams of Dipping Its Toe Into Social Networking Waters
- FDA's Answer to ePharma Marketing Guidelines: "circles and arrows and a paragraph on the back"
- FDA Widgets: How About One for Adverse Event Reporting?
- Tit-for-Tat Tithe on Pharma Marketing. How It Can Work.
- FDA's Answer to ePharma Marketing Guidelines: "circles and arrows and a paragraph on the back"
- Viagra Print Ad Art Imitates Life as it Could be Without FDA Regulations
- Drug Fact Box: It All Depends on What You Mean by "Fact"
- New "New Media" Trick for Pharma Marketers
- An Avodart Print Ad that FDA Missed
- FDA Warns GSK About Enlarged Avodart Ad Imagery
- Ethical Pharma Marketing
- Amgen's Bike Jersey Tchotchke Available
- Are FDA Penalties No Longer a "Slap on the Wrist?"
- YAZ Commercial Yanked from TV, But Not from YouTube
- "FDA a Failed Agency" says Dr. Steven Nissen, Contender for FDA Commissioner
- FDA's New "Good Reprint" Guidance: Off-Label Promotion to Docs is Now Virtually Unregulated
Posted in 2008:
Posted in 2007:
Posted in 2006:
For access to the following posts, please use the Monthly Archive.
- The Next Blockbuster - You Decide!
- Where's DDMAC's Head At?
- Celebrex Joins the bAdWord Bandwagon!
- Off-Label Confusion
- Lame-Duck Senate Roasts Eschenbach Turkey!
- Pay Per DTC Ad View Update
- Wooing Dems: Thank You Mr. Kindler!
- What's In Store from Congress?
- The "Girl from Google"
- Clear Words, Obscure Benefits
- Lunesta, Google, and "bAdWords"
- Rozerem Sleeper Cell at Pri-Med Conference
- Apres IOM, le Deluge!
- IOM Report Calls for DTC Moratorium
- Pay-(FDA)-Per-(Pre)View of DTC
- WLF: A No-Risk Ad is a Good Ad
- Accountability: Imported vs. Domestic
- Fear & Loathing in Bethesda
- FDA Paralyzed: Who Will Protect Us?
- FDA Gets a "C" from the Public
- Licensing Sales Reps: Is It a Bad Idea?
- Celsius 3014: Ketek, Drug Safety, & Bioterrorism
- Spinning Bad News about FDA & Drug Safety
- FDA Coming to a Mall Near You?
- Merck Misled FDA According to NJ Jury
- FDA Backs Down on Coupon Study
- Off-label Marketing: Next State Issue
- FDA, Coupons, and Sleep Aid DTC Ads
- Gifts That Keep on Giving
Posted in 2005:
For access to the following posts, please use the Monthly Archive.
- AstraZeneca's Risky Proposition
- Plan B FDAgate
- FDA DTC Hearings Day 2
- FDA DTC Hearings: Snippets from Day 1
- DTC Regulation: Trick or Treat?
- New Assault on Pharma Marketing?
- FDA May Follow PhRMA's Lead on DTC
- Ethical Pharma Marketing: Oxymoronic?
- Bloggers Worry Pharma More Than FDA
- HELP WANTED: Director of Drug Safety
- PhRMA Finalizes DTC Principles
- Restrict DTC, but Extend the Patent for New Drugs
- To Ban or Not to Ban DTC, That is the Question
- WLF Watches FDA Watching Drug Ads
- New DTC Principles Emerging
- How the FDA Can Fix DTC
- Proposal for a Drug Risk Advisory System
- FDA Drug Watch Site Guidelines
- Separation of Church and State
- "Bioshield" Boondoggle
- FDA Advisory Panels: Elephants in the Room
- Does the FDA Need to be Overhauled?
- Buzz is NOT regulated by FDA
Pharma Marketing News |
Subscribe |
Discussion Forums |
Roundtable |
Podcasts |
Blog
Daily News Briefs |
Surveys |
Resources/Links |
Glossary |
Case Studies |
Reports
Pharma Marketing Vendor Directory |
Conference Calendar |
Pharma Jobs
Advertising Information |
FAQs |
About Us |
Privacy Policy
© 2005-2009. VirSci Corporation.
All rights reserved.
|
| Find a Vendor |
Pharma Marketing Vendor Directory
Hundreds of pharmaceutical marketing services vendors, consultants, executive search firms, medical education companies, and other companies servicing the needs of the pharmaceutical industry.
Learn More Access Listings
|
| Network |
Online Discussion & Networking Forums
Network with your peers in the industry, seek help advancing your career, discuss current issues.
Learn More
|
| Advertise |
Promote Your Products and Services
Pharma Marketing Network & Pharma Marketing News provide exceptional permission-based e-marketing opportunities.
Learn More Media Kit
Get Rate Card Click Here
|
| Meet |
Attend Industry Conferences and Seminars
Pharma Marketing News is proud to be a media partner for dozens of industry conferences.
Conference Calendar
Get Your Event Listed Click Here
|
| Find a Job |
Get Help Finding a Job in the Pharma Industry
Post your resume to the Pharma Marketing Network Job Exchange Forum where you can also find help from colleagues.
Employers interested in announcing job openings should contact us.
|
|